Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.21 EUR
86.19 M EUR
874.28 M EUR
33.27 M
About HISAMITSU PHARMACEUTICAL CO INC
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat brands. It also provides ethical pharmaceuticals, over- the-counter drugs, medical devices, health supplements, and topical analgesic products. The company was founded by Nihei Hisamitsu in 1847 and is headquartered in Tosu, Japan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HPX is 25.60 EUR — it has increased by 1.60% in the past 24 hours. Watch HISAMITSU PHARMACEUTICAL CO INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange HISAMITSU PHARMACEUTICAL CO INC stocks are traded under the ticker HPX.
HPX stock has risen by 2.42% compared to the previous week, the month change is a −2.31% fall, over the last year HISAMITSU PHARMACEUTICAL CO INC has showed a −8.57% decrease.
We've gathered analysts' opinions on HISAMITSU PHARMACEUTICAL CO INC future price: according to them, HPX price has a max estimate of 27.59 EUR and a min estimate of 27.59 EUR. Watch HPX chart and read a more detailed HISAMITSU PHARMACEUTICAL CO INC stock forecast: see what analysts think of HISAMITSU PHARMACEUTICAL CO INC and suggest that you do with its stocks.
HPX stock is 0.79% volatile and has beta coefficient of 0.29. Track HISAMITSU PHARMACEUTICAL CO INC stock price on the chart and check out the list of the most volatile stocks — is HISAMITSU PHARMACEUTICAL CO INC there?
Today HISAMITSU PHARMACEUTICAL CO INC has the market capitalization of 1.94 B, it has increased by 2.09% over the last week.
Yes, you can track HISAMITSU PHARMACEUTICAL CO INC financials in yearly and quarterly reports right on TradingView.
HISAMITSU PHARMACEUTICAL CO INC is going to release the next earnings report on Jan 9, 2025. Keep track of upcoming events with our Earnings Calendar.
HPX net income for the last quarter is 26.68 M EUR, while the quarter before that showed 28.07 M EUR of net income which accounts for −4.95% change. Track more HISAMITSU PHARMACEUTICAL CO INC financial stats to get the full picture.
HISAMITSU PHARMACEUTICAL CO INC dividend yield was 2.19% in 2023, and payout ratio reached 46.80%. The year before the numbers were 2.21% and 57.10% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 23, 2024, the company has 2.76 K employees. See our rating of the largest employees — is HISAMITSU PHARMACEUTICAL CO INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HISAMITSU PHARMACEUTICAL CO INC EBITDA is 120.03 M EUR, and current EBITDA margin is 12.94%. See more stats in HISAMITSU PHARMACEUTICAL CO INC financial statements.
Like other stocks, HPX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HISAMITSU PHARMACEUTICAL CO INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HISAMITSU PHARMACEUTICAL CO INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HISAMITSU PHARMACEUTICAL CO INC stock shows the neutral signal. See more of HISAMITSU PHARMACEUTICAL CO INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.